Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction.

Author:

Chiariello M,Gold H K,Leinbach R C,Davis M A,Maroko P R

Abstract

This clinical and experimental investigation was designed to delineate and compare the relative effects of sodium nitroprusside (NP) and nitroglycerin (TNG) on electrocardiographic ischemic injury following acute myocardial infarction in patients and following coronary artery occlusion in dogs. Accordingly, in ten patients with anterior acute myocardial infarction and ST-segment elevation stable for 60 min, the effects of NP (average 95 mug/min i.v.) and TNG (average 0.48 mg sublingually) were studied. The hemodynamic actions of NP and TNG were directionally similar. However, NP increased average ST-segment elevation (ST) by 2.0 +/- 0.2 mm, while TNG reduced ST by 1.4 +/- 0.4 mm. In order to clarify this disparity, coronary artery occlusions were carried out in 14 open-chest dogs. During control, NP and TNG time periods, epicardial electrograms were recorded and regional myocardial blood flow (RMBF) determined by the microsphere technique. Nitropruside increased ST-segment elevation from 4.6 +/- 0.6 to 5.7 +/- 0.6 mV (P less than 0.05) and reduced RMBF from 35 +/- 3 to 27 +/- 2 ml/min/100 g (P less than 0.01) in the ischemic zones. In contrast, TNG reduced ST-segment elevation from 4.9 +/- 0.7 to 3.0 +/- 0.7 mV (P less than 0.05), while increasing RMBF TO 43 +/0 4 ml/min/100 G (P less than 0.05) and the endo/epicardial ratio from 0.57 +/- 0.06 to 0.69 +/- 0.07 (P less than 0.01). Although TNG and NP exhibit similar hemodynamic effects, TNG reduced electrocardiographic ischemic injury, at least in part, by increasing perfusion of the ischemic areas and redistributing it favorably, while NP increased electrocardiographic ischemic injury, at least in part, by reducing perfusion. Therefore, TNG seems preferable to NP for reducing preload and afterload in patients during the early phase of acute myocardial infarction.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Cited by 378 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. The Management of Hypertensive Emergencies—Is There a “Magical” Prescription for All?;Journal of Clinical Medicine;2022-05-31

2. Treatment of Perioperative Ischemia, Infarction, and Ventricular Failure in Cardiac Surgery;Perioperative Medicine;2022

3. Hypertensive Krise;Medikamente in der Urologie;2021

4. Pharmacology of Cardiovascular Drugs;Critical Heart Disease in Infants and Children;2019

5. ESC Council on hypertension position document on the management of hypertensive emergencies;European Heart Journal - Cardiovascular Pharmacotherapy;2018-08-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3